- Home
- PRKS vs HTFL Comparison
PRKS vs HTFL Comparison
Compare PRKS & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRKS | HTFL |
|---|---|---|
| Founded | 1959 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2012 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PRKS | HTFL |
|---|---|---|
| Price | $45.22 | $45.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $47.50 | $38.20 |
| AVG Volume (30 Days) | 667.4K | ★ 1.7M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $1,263,324,000.00 | $176,034,000.00 |
| Revenue This Year | $3.45 | $27.66 |
| Revenue Next Year | $3.08 | $23.55 |
| P/E Ratio | $75.05 | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $28.77 | $20.13 |
| 52 Week High | $56.95 | $45.33 |
Technical Indicators
Market Signals| Indicator | PRKS | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 52.26 | 86.01 |
| Support Level | $44.00 | $24.59 |
| Resistance Level | $49.08 | N/A |
| Average True Range (ATR) | 1.94 | 2.22 |
| MACD | -0.01 | 2.24 |
| Stochastic Oscillator | 35.71 | 94.15 |
Price Performance
Historical ComparisonAbout PRKS United Parks & Resorts Inc.
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.